GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Panagene Co Ltd (XKRX:046210) » Definitions » Cash-to-Debt

HLB Panagene Co (XKRX:046210) Cash-to-Debt : 2.96 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is HLB Panagene Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. HLB Panagene Co's cash to debt ratio for the quarter that ended in Mar. 2024 was 2.96.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, HLB Panagene Co could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for HLB Panagene Co's Cash-to-Debt or its related term are showing as below:

XKRX:046210' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.16   Med: 101.29   Max: No Debt
Current: 2.96

During the past 13 years, HLB Panagene Co's highest Cash to Debt Ratio was No Debt. The lowest was 0.16. And the median was 101.29.

XKRX:046210's Cash-to-Debt is ranked worse than
60.82% of 1521 companies
in the Biotechnology industry
Industry Median: 6.39 vs XKRX:046210: 2.96

HLB Panagene Co Cash-to-Debt Historical Data

The historical data trend for HLB Panagene Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

HLB Panagene Co Cash-to-Debt Chart

HLB Panagene Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 255.17 311.64 152.96 95.89 3.31

HLB Panagene Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.46 95.01 5.99 3.31 2.96

Competitive Comparison of HLB Panagene Co's Cash-to-Debt

For the Biotechnology subindustry, HLB Panagene Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Panagene Co's Cash-to-Debt Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Panagene Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where HLB Panagene Co's Cash-to-Debt falls into.



HLB Panagene Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

HLB Panagene Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

HLB Panagene Co's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLB Panagene Co  (XKRX:046210) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


HLB Panagene Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of HLB Panagene Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Panagene Co (XKRX:046210) Business Description

Traded in Other Exchanges
N/A
Address
54, Techno 10-ro, Yuseong-gu, Daejeon, KOR, 34027
HLB Panagene Co Ltd Formerly PANAGENE Inc is a South Korea based company engages in the molecular diagnostics business. It develops, manufactures and sells peptide nucleic acid (PNA) genetic diagnostic chips.

HLB Panagene Co (XKRX:046210) Headlines

No Headlines